Showing results (61-70 of 376) with videos related to

Sort By:
Pageof 38
The Journal of Pediatrics|December 22, 2018
Can Pediatric Practitioners Correctly Interpret Electrocardiograms?Sahil Khanna, V Ramesh Iyer, Victoria L Vetter
Mayo Clinic Proceedings|April 6, 2020
Update on Treatment of Clostridioides difficile InfectionJanice M Cho, Darrell S Pardi, Sahil Khanna
Journal of Clinical Gastroenterology|December 24, 2016
Outcomes With Fidaxomicin Therapy in Clostridium difficile InfectionClayton M Spiceland, Sahil Khanna, Darrell S Pardi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 4, 2025
Effectiveness and Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Immunocompromised PatientsParul Berry, Raseen Tariq, Darrell Pardi, et al.
Gastroenterology|January 14, 2021
Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionSrishti Saha, Kristin Mara, Darrell S Pardi, et al.
Leukemia & Lymphoma|April 19, 2021
CAR-T cell persistence in the treatment of leukemia and lymphomaArjun Gupta, Saar Gill
The American Journal of Gastroenterology|June 22, 2026
Cost-effectiveness of Microbiota Restoration Therapies for Recurrent Clostridioides difficile InfectionParul Berry, Vishwesh Bharadiya, Darrell S Pardi, et al.
Plos One|May 28, 2021
Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replicationChad Artman, Kyle D Brumfield, Sahil Khanna, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile InfectionSrishti Saha, Kristin Mara, Darrell S Pardi, et al.
Inflammatory Bowel Diseases|September 28, 2018
Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile InfectionDipesh Solanky, Darrell S Pardi, Edward V Loftus, et al.
Pageof 38